โš™

Pathophysiology Nodes

4
4 shared nodes are defined in this module.
โ—‰

Cell Types

3
astrocyte CL:0000127 neuron CL:0000540 motor neuron CL:0000100
โ‡„

Biological Processes

5
neurotransmitter transport GO:0006836 DECREASED calcium ion transmembrane transport GO:0070588 INCREASED response to oxidative stress GO:0006979 INCREASED mitochondrion organization GO:0007005 DYSREGULATED neuron apoptotic process GO:0051402 INCREASED
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "glutamate_excitotoxicity#Excitotoxic Neuronal Death", the key conformance target). It models the conserved excitotoxic cascade shared across amyotrophic lateral sclerosis (impaired astrocytic glutamate clearance; the antiglutamate drug riluzole is a partial validation), the cyanobacterial-toxin disorders (BMAA acting at AMPA/kainate and NMDA/mGluR5 receptors in Guam ALS-PDC), methylmercury poisoning (NMDA-receptor-mediated injury), Huntington disease, and epilepsy-associated neuronal injury. It is intentionally distinct from the epilepsy_excitation_inhibition_imbalance module, which models hyper-synchronous network firing producing seizures rather than the receptor-overactivation calcium-overload cell-death cascade modeled here. Conforming nodes may be partial where excitotoxicity is one of several parallel injury mechanisms (e.g., the oxidative-stress-dominant methylmercury and BMAA mechanisms).
โ†—

Used By Disorder Entries

3
โฌก

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Glutamate Excitotoxicity Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
โš™

Pathophysiology

4
Excessive Glutamatergic Stimulation and Impaired Glutamate Clearance
trigger
The shared initiating condition is a pathological rise in glutamatergic receptor stimulation. This arises from impaired astrocytic glutamate clearance (loss of the EAAT2/GLT-1 transporter), increased presynaptic glutamate release, or exogenous excitotoxins โ€” including BMAA, which additionally inhibits the cystine/glutamate antiporter (system xc-) to raise extracellular glutamate and deplete glutathione.
astrocyte CL:0000127
neurotransmitter transport GO:0006836 DECREASED
Glutamate Receptor Overactivation and Calcium Overload
central effector
Sustained overactivation of NMDA, AMPA, and kainate glutamate receptors opens cation channels and produces pathological intracellular calcium influx and overload. The calcium overload is the proximate injurious signal that couples excessive receptor activation to downstream organelle dysfunction and death. Motor neurons are selectively vulnerable owing to their calcium-permeable AMPA-receptor complement.
neuron CL:0000540
calcium ion transmembrane transport GO:0070588 INCREASED
Mitochondrial Dysfunction and Oxidative Stress
amplifier
Calcium overload is taken up by mitochondria, impairing oxidative phosphorylation, collapsing membrane potential, and generating reactive oxygen species. Excitotoxins compound this directly: BMAA and methylmercury both induce neuronal oxidative stress. The resulting bioenergetic failure and ROS burden amplify the injury and lower the threshold for neuronal death.
neuron CL:0000540
response to oxidative stress GO:0006979 INCREASED mitochondrion organization GO:0007005 DYSREGULATED
Excitotoxic Neuronal Death
effector
The convergent endpoint is death of the selectively vulnerable neuronal population through calcium- and ROS-dependent effectors (calpains, nitric oxide synthase, mitochondrial permeability transition) producing apoptotic and necrotic neuronal loss. This is the key conformance target: disorders substitute their specific glutamatergic insult and vulnerable neurons while sharing this excitotoxic death.
motor neuron CL:0000100 neuron CL:0000540
neuron apoptotic process GO:0051402 INCREASED